Section Arrow
GRCE.NASDAQ
- Grace Therapeutics Inc
Quotes are at least 15-min delayed:2026/02/19 06:27 EST
Pre Market
Last
 --
-- (--)
Bid
3.65
Ask
4.17
High -- 
Low -- 
Volume -- 
Regular Hours (Closed)
Last
 3.95
+0.01 (+0.25%)
Day High 
4.04 
Prev. Close
3.94 
1-M High
4.1 
Volume 
64.89K 
Bid
3.65
Ask
4.17
Day Low
3.94 
Open
4.03 
1-M Low
3.4 
Market Cap 
60.97M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 3.64 
20-SMA 3.66 
50-SMA 3.55 
52-W High 4.1 
52-W Low 1.75 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.53/-1.41
Enterprise Value
60.97M
Balance Sheet
Book Value Per Share
4.06
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
QNCXQuince Therapeutics0.178-0.007-3.78%-- 
Pre Market 0.1783 +0.0003 +0.17%
IBRXImmunityBio8.54+2.52+41.86%-- 
Pre Market 8.57 +0.03 +0.35%
CDIOCardio Diagnostics Holdings Inc.2.13+0.94+78.99%-- 
Pre Market 2.03 -0.1 -4.69%
RXRXRecursion Pharmaceuticals3.53+0.07+2.02%-- 
Pre Market 3.44 -0.09 -2.55%
GERNGeron Corp1.94+0.14+7.78%-- 
Pre Market 1.935 -0.005 -0.26%
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Grace Therapeutics Inc is a late-stage specialty pharma company with drug delivery technologies and drug candidates addressing rare and orphan diseases. The company's lead drug candidate, GTx-104, is a novel injectable formulation of nimodipine for the treatment of a rare disease, aneurysmal subarachnoid hemorrhage. Other products are GTx-102 Ataxia-Telangiectasia, GTx-101 Postherpetic Neuralgia, and GTx-201.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.